|
Lipid and lipoprotein metabolism
Citations 61-70 of 547 total displayed.
|
Past content
(since Jan 1999):
|
- Articles
Inhibition of Stearoyl-Coenzyme A Desaturase 1 Dissociates Insulin Resistance and Obesity From Atherosclerosis
- J. Mark Brown, Soonkyu Chung, Janet K. Sawyer, Chiara Degirolamo, Heather M. Alger, Tam Nguyen, Xuewei Zhu, My-Ngan Duong, Amanda L. Wibley, Ramesh Shah, Matthew A. Davis, Kathryn Kelley, Martha D. Wilson, Carol Kent, John S. Parks, and Lawrence L. Rudel
Circulation published September 15, 2008, doi:10.1161/CIRCULATIONAHA.108.793182
[Abstract]
- Articles
Activation of Liver X Receptors Promotes Neuroprotection and Reduces Brain Inflammation in Experimental Stroke
- Jesús R. Morales, Iván Ballesteros, José Manuel Deniz, Olivia Hurtado, José Vivancos, Florentino Nombela, Ignacio Lizasoain, Antonio Castrillo, and María A. Moro
Circulation published September 15, 2008, doi:10.1161/CIRCULATIONAHA.108.782300
[Abstract]
- Editorials
Inhibition of Lipoprotein-Associated Phospholipase Activity by Darapladib: Shifting Gears in Cardiovascular Drug Development: Are Antiinflammatory Drugs the Next Frontier?
- S. Matthijs Boekholdt, Robbert J. de Winter, and John J.P. Kastelein
Circulation 2008;118:1120-1122, doi:10.1161/CIRCULATIONAHA.108.795195
[Full text]
- Articles
Combined Statin and Niacin Therapy Remodels the High-Density Lipoprotein Proteome
- Pattie S. Green, Tomas Vaisar, Subramaniam Pennathur, J. Jacob Kulstad, Andrew B. Moore, Santica Marcovina, John Brunzell, Robert H. Knopp, Xue-Qiao Zhao, and Jay W. Heinecke
Circulation published September 2, 2008, doi:10.1161/CIRCULATIONAHA.108.770669
[Abstract]
- Epidemiology
Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- Samia Mora, Nader Rifai, Julie E. Buring, and Paul M Ridker
Circulation 2008;118:993-1001; published online before print as doi:10.1161/CIRCULATIONAHA.108.777334
[Abstract]
[Full text]
- Articles
Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- Samia Mora, Nader Rifai, Julie E. Buring, and Paul M Ridker
Circulation published August 18, 2008, doi:10.1161/CIRCULATIONAHA.108.777334
[Abstract]
- Editorials
Apolipoprotein CIII and Atherosclerosis: Beyond Effects on Lipid Metabolism
- Alex Bobik
Circulation 2008;118:702-704, doi:10.1161/CIRCULATIONAHA.108.794081
[Full text]
- Vascular Medicine
Apolipoprotein CIII Links Hyperlipidemia With Vascular Endothelial Cell Dysfunction
- Akio Kawakami, Mizuko Osaka, Mariko Tani, Hiroshi Azuma, Frank M. Sacks, Kentaro Shimokado, and Masayuki Yoshida
Circulation 2008;118:731-742; published online before print as doi:10.1161/CIRCULATIONAHA.108.784785
[Abstract]
[Full text]
- Vascular Medicine
Antisense Oligonucleotide Directed to Human Apolipoprotein B-100 Reduces Lipoprotein(a) Levels and Oxidized Phospholipids on Human Apolipoprotein B-100 Particles in Lipoprotein(a) Transgenic Mice
- Esther Merki, Mark J. Graham, Adam E. Mullick, Elizabeth R. Miller, Rosanne M. Crooke, Robert E. Pitas, Joseph L. Witztum, and Sotirios Tsimikas
Circulation 2008;118:743-753; published online before print as doi:10.1161/CIRCULATIONAHA.108.786822
[Abstract]
[Full text]
- Contemporary Reviews in Cardiovascular Medicine
Evidence Mandating Earlier and More Aggressive Treatment of Hypercholesterolemia
- Daniel Steinberg, Christopher K. Glass, and Joseph L. Witztum
Circulation 2008;118:672-677, doi:10.1161/CIRCULATIONAHA.107.753152
[Full text]
|
|
